A carregar...
PET imaging of tumor angiogenesis in mice with VEGF-A targeted (86)Y-CHX-A″-DTPA-bevacizumab
Bevacizumab is a humanized monoclonal antibody that binds to tumor-secreted VEGF-A and inhibits tumor angiogenesis. In 2004, the antibody was approved by the United States FDA for the treatment of metastatic colorectal carcinoma in combination with chemotherapy. This report describes the preclinical...
Na minha lista:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2939172/ https://ncbi.nlm.nih.gov/pubmed/20473899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.25409 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|